Unknown

Dataset Information

0

Endothelial nitric oxide synthase controls the expression of the angiogenesis inhibitor thrombospondin 2.

ABSTRACT: Injury- and ischemia-induced angiogenesis is critical for tissue repair and requires nitric oxide (NO) derived from endothelial nitric oxide synthase (eNOS). We present evidence that NO induces angiogenesis by modulating the level of the angiogenesis inhibitor thrombospondin 2 (TSP2). TSP2 levels were higher than WT in eNOS KO tissues in hind-limb ischemia and cutaneous wounds. In vitro studies confirmed that NO represses TSP2 promoter activity. Moreover, double-eNOS/TSP2 KO mice were generated and found to rescue the phenotype of eNOS KO mice. Studies in mice with knock-in constitutively active or inactive eNOS on the Akt-1 KO background showed that eNOS activity correlates with TSP2 levels. Our observations of NO-mediated regulation of angiogenesis via the suppression of TSP2 expression provide a description of improved eNOS KO phenotype by means other than restoring NO signaling.

SUBMITTER: MacLauchlan S 

PROVIDER: S-EPMC3219156 | biostudies-literature | 2011 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Endothelial nitric oxide synthase controls the expression of the angiogenesis inhibitor thrombospondin 2.

MacLauchlan Susan S   Yu Jun J   Parrish Marcus M   Asoulin Tara A TA   Schleicher Michael M   Krady Marie M MM   Zeng Jianmin J   Huang Paul L PL   Sessa William C WC   Kyriakides Themis R TR  

Proceedings of the National Academy of Sciences of the United States of America 20110926 46

Injury- and ischemia-induced angiogenesis is critical for tissue repair and requires nitric oxide (NO) derived from endothelial nitric oxide synthase (eNOS). We present evidence that NO induces angiogenesis by modulating the level of the angiogenesis inhibitor thrombospondin 2 (TSP2). TSP2 levels were higher than WT in eNOS KO tissues in hind-limb ischemia and cutaneous wounds. In vitro studies confirmed that NO represses TSP2 promoter activity. Moreover, double-eNOS/TSP2 KO mice were generated  ...[more]

Similar Datasets

Unknown NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation.
| S-EPMC3589548 | biostudies-literature
Unknown Regulation of retinal angiogenesis by endothelial nitric oxide synthase signaling pathway.
| S-EPMC5015000 | biostudies-literature
Unknown The histone deacetylase inhibitor tubacin mitigates endothelial dysfunction by up-regulating the expression of endothelial nitric oxide synthase.
| S-EPMC6926467 | biostudies-literature
Unknown Effect of nuclear actin on endothelial nitric oxide synthase expression.
| S-EPMC1382336 | biostudies-literature
Unknown Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability.
| S-EPMC30185 | biostudies-literature
Unknown Endothelial nitric oxide synthase-derived nitric oxide in the regulation of metabolism.
| S-EPMC7531049 | biostudies-literature
Unknown Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent.
| S-EPMC3939925 | biostudies-literature
Unknown (-)-epicatechin activation of endothelial cell endothelial nitric oxide synthase, nitric oxide, and related signaling pathways.
| S-EPMC2874202 | biostudies-literature
Unknown Endothelial nitric oxide synthase in the microcirculation.
| S-EPMC4628887 | biostudies-literature
Unknown Vascular and perivascular nitric oxide release and transport: biochemical pathways of neuronal nitric oxide synthase (NOS1) and endothelial nitric oxide synthase (NOS3).
| S-EPMC1987713 | biostudies-literature